Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.94
+0.45 (1.58%)
At close: Feb 27, 2026, 4:00 PM EST
29.00
+0.06 (0.21%)
After-hours: Feb 27, 2026, 7:42 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
|---|
Discovery, Development and Commercialization of Medicines and Technologies | 29.05M | 32.71M | 31.53M | 55.29M | 23.80M | | |
Discovery, Development and Commercialization of Medicines and Technologies Growth | -11.19% | 3.75% | -42.97% | 132.34% | -64.85% | | |
| 29.05M | 32.71M | 31.53M | 55.29M | 23.80M | | |
| -11.19% | 3.75% | -42.97% | 132.34% | -64.85% | | |
Source: S&P Global Market Intelligence.
